Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole

Oral Diseases

Volumn 8, Issue 4, 2002, Pages 199-206

  Anil, S ^a   Samaranayake, L P ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antifungals; Candida; Lactoferrin; Lysozyme

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; LACTOFERRIN; LYSOZYME; NYSTATIN; POLYENE; PYRROLE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA TROPICALIS; CELL VIABILITY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXPOSURE; FUNGUS ISOLATION; MOUTH INFECTION; NONHUMAN; PRIORITY JOURNAL; YEAST; ANALYSIS OF VARIANCE; BACTERIAL COUNT; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUTH; SPECIES DIFFERENCE; STATISTICS;

AMPHOTERICIN B; ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDA TROPICALIS; COLONY COUNT, MICROBIAL; FLUCONAZOLE; HUMAN; LACTOFERRIN; MICROBIAL SENSITIVITY TESTS; MOUTH; MURAMIDASE; NYSTATIN; SPECIES SPECIFICITY; STATISTICS; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0036021296     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-0825.2002.01818.x     Document Type: Article

References (33)

1. Post-antifugal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease
2. Oral manifestations of HIV infection in 600 South African patients
3. Evaluation of the modified API 20C system for identification of clinically important yeasts
4. Non-albicans oral candidosis in HIV-positive patients
5. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates
6. Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents
7. Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents
8. The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans
9. Antimycotic agents in oral candidosis: An overview: 1. Clinical variants
10. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin
11. Lytic sensitivity of Actinobacillus actinomycetemcomitans Y4 to lysozyme
12. Lysozyme-mediated de-chaining of Streptococcus mutans and its antibacterial significance in an acidic environment
13. Lytic action of lysozyme on Candida albicans
14. Characterization of lactoferrin interaction with Streptococcus mutant
15. Cell walls of normal and lysozyme-damaged blastoconidia of Candida albicans: Localization of surface factor 4 antigen and vicinal-glycol staining
16. Antifungal agents
17. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time
18. Saliva - The defender of the oral cavity
19. Binding of salivary or serum proteins to Candida albicans in vitro
20. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei
21. Synergy of lysozyme and lanoconazole on the morphology of Candida albicans
22. Oropharyngeal candidiasis in patients with HIV: Suggested guidelines for therapy
23. Oral mycoses in HIV infection
24. The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media
25. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity
26. Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort
27. Fungicidal effect of human lactoferrin against Candida albicans
28. Salivary lysozyme, lactoferrin and peroxidases: Antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry
29. In vitro susceptibility of Candida species to lysozyme
30. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents
31. Multi-centre evaluation of the E-test method for antifungal drug susceptibility testing of Candida spp. & Cryptococcus neoformans
32. Clinical, cellular and molecular factors that contribute to antifungal drug resistance